As health systems across the world face unprecedented post-corona challenges, nine Israeli digital health startups were chosen by Jerusalem Venture Partners (JVP), pharmaceutical giant AstraZeneca and the ii2020 National Initiative for their new PlayBeyondBio mentoring and development program.

The six-month fast track accelerator will operate in collaboration with Microsoft for Startups, Cisco, Kahn-Sagol Maccabi Research Innovation Institute and Sha’are Zedek Medical Center in Jerusalem. These strategic partners will accompany the participating companies through all stages of the process, including possible commercial arrangements and investment.

The companies selected to participate in PlayBeyondBio:

Biobeat — developing a wearable for remote noninvasive medical-grade monitoring of blood pressure, heart rate, respiratory rate, saturation, temperature and more complex vital signs.

Bio-T -– a cloud platform enabling medical device manufacturers to quickly upgrade any standalone device to an online “medical device as a service” providing remote care.

DiA Imaging Analysis — an AI-based technology enabling clinicians with all levels of experience to identify abnormalities on ultrasounds. The Israel Innovation Authority recently awarded a grant to DiA for rapid ultrasound analysis of Covid-19 patients at risk of heart complications. DiA has partnerships with eight ultrasound vendors, including GE Healthcare, IBM Watson and Konica Minolta. Its solution currently serves more than 1,000 clinicians globally.

Docdok.health – the “Netflix of healthcare” helps monitor symptoms via disease-specific apps for patients not under direct medical supervision.

Flaskdata.io — real-time clinical trial platform would significantly reduce medical experiment stage of drug and vaccine development, using AI technology.

IDEA Bio-Medical – an AI-powered decision support system that significantly improves the ability to analyze biopsies and make decisions regarding cancer treatment.

Resmetrix — a wireless wearable to monitor respiratory patterns of at-risk patients, especially those with COPD.

Serenus.AI – patented AI-based post-diagnostic platform aims to help reduce the number of unnecessary surgeries and medical prescriptions.

TimeStamp – an electronic smart sticker that records prescription meds usage history, especially for people with asthma, adaptable to most inhalers without patient engagement.